Entering text into the input field will update the search result below

Mylan launches generic for Prevacid SoluTab DR ODT

  • Mylan N.V. (MYL) announces the U.S. launch of Lansoprazole Delayed-Release (DR) Orally Disintegrating Tablets (ODT), 15 mg and 30 mg, a generic version of Takeda's Prevacid SoluTab DR ODT.
  • Mylan received final FDA approval for its ANDA for this product, which has the same indications as the reference listed drug, including treatment of active ulcers of the stomach and small intestine, gastroesophageal reflux disease and Zollinger-Ellison syndrome.
  • U.S. sales for Lansoprazole DR ODT, 15 mg and 30 mg, were ~$168M for the year ending September 30, 2018, according to IQVIA.

Recommended For You

About VTRS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VTRS--
Viatris Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.